Propensity of gynaecologists towards osteoporosis management and treatment

Maturitas

Volumn 53, Issue 4, 2006, Pages 483-488

  Rozenberg, Serge ^a   Murillo, Daniel ^a   Gevers, Rudy ^a   Vandromme, Jean ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Gynaecologists; Osteoporosis management; Survey; Treatment

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

BONE DENSITOMETRY; GYNECOLOGY; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; OSTEOPENIA; OSTEOPOROSIS; PHYSICIAN ATTITUDE; PRESCRIPTION; REVIEW; RISK FACTOR; SCREENING; VITAMIN SUPPLEMENTATION;

EID: 33644636095     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.08.004     Document Type: Article

References (29)

1. F. Cosman, J. Nieves, J. Horton, V. Shen, and R. Lindsay Effects of estrogen on response to edetic acid infusion in postmenopausal osteoporotic women J Clin Endocrinol Metab 78 1994 939 943
2. W.R. McKane, S. Khosla, and M.F. Burritt Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause: a clinical research center study J Clin Endocrinol Metab 80 1995 3458 3464
3. C.J. Rosen, and C.R. Kessenich The pathophysiology and treatment of postmenopausal osteoporosis: an evidence-based approach to estrogen replacement therapy Endocrinol Metab Clin North Am 26 1997 295 311
4. L. Ferrucci, T.B. Harris, and J.M. Guralnik Serum IL-6 level and the development of disability in older persons J Am Geriatr Soc 47 1999 639 646
5. T.V. Dennis, F.B. Ellen, B.W. Daniel, B.S. Kenneth, E.Y. Kevin, and M.K. Wendy Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial JAMA 286 2001 815 820
6. B. Lees, and J.C. Stevenson The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol-17 beta and dydrogesterone Osteoporos Int 12 2001 251 258
7. E. Banks, V. Beral, G. Reeves, A. Balkwill, I. Barnes Million Women Study Collaborators Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women JAMA 291 18 2004 2212 2220
8. F. Grodstein, T.B. Clarkson, and J.E. Manson Understanding the divergent data on postmenopausal hormone therapy N Engl J Med 348 7 2003 645 650
9. J.D. Wagner, and T.B. Clarkson The applicability of hormonal effects on atherosclerosis in animals to heart disease in postmenopausal women Semin Reprod Med 23 2 2005 149 156
10. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis Am J Med 94 6 1993 646 650
11. J.E. Rossouw Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 3 2002 321 333
12. EMEA December 2003/33065/03 (http://www.emea.eu.int/pdfs/human/press/pus/ 3306503en.pdf).
13. U.A. Liberman, S.R. Weiss, and J. Broll Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis N Engl J Med 333 1995 1437 1443
14. D.M. Black, S.R. Cummings, and D.B. Karpf Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 348 1996 1535 1541
15. B. Ettinger, D.M. Black, and B.H. Mitlak Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple outcomes of raloxifene evaluation (MORE) investigators JAMA 282 1999 637 645
16. M. Maricic, J.D. Adachi, S. Sarkar, W. Wu, M. Wong, and K.D. Harper Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis Arch Intern Med 162 2002 1140 1143
17. G.L. Anderson, M. Limacher, and A.R. Assaf Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 14 2004 1701 1712
18. P.Y. Scarabin, E. Oger, G. Plu-Bureau EStrogen and THromboEmbolism Risk Study Group Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk Lancet 362 9382 2003 428 432
19. A. Fournier, F. Berrino, E. Riboli, V. Avenel, and F. Clavel-Chapelon Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort Int J Cancer 114 3 2005 448 454
20. A.M. Cheung, D.S. Feig, M. Kapral, N. Diaz-Granados, S. Dodin Canadian Task Force on Preventive Health Care Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care CMAJ 170 11 2004 1665 1667
21. S. Rozenberg, M. Kroll, J. Vandromme, M. Paesmans, A. Lefever, and H. Ham Factors influencing the prescription of hormone replacement therapy Obstet Gynecol 90 3 1997 387 391
22. L. Speroff, J. Rowan, J. Symons, H. Genant, and W. Wilborn The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial JAMA 276 17 1996 1397 1403
23. S. Rozenberg, O. Ylikorkala, and S. Arrenbrecht Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids Int J Fertil Womens Med 42 Suppl. 2 1997 376 387
24. M. Gambacciani, M. Ciaponi, and B. Cappagli Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women Maturitas 50 2 2005 91 97
25. M.C. Chapuy, M.E. Arlot, and F. Duboeuf Vitamin D3 and calcium to prevent hip fractures in the elderly women N Engl J Med 327 1992 1637 1642
26. B. Dawson-Hughes, S.S. Harris, E.A. Krall, and G.E. Dallal Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older N Engl J Med 337 1997 670 676
27. P. Lips, W.C. Graafmans, M.E. Ooms, P.D. Bezemer, and L.M. Bouter Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial Ann Intern Med 124 1996 400 406
28. A.M. Grant, A. Avenell, and M.K. Campbell Oral Vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (randomised evaluation of calcium or Vitamin D, RECORD): a randomised placebo-controlled trial Lancet 365 9471 2005 1621 1628
29. J. Porthouse, S. Cockayne, and C. King Randomised controlled trial of calcium and supplementation with cholecalciferol (Vitamin D3) for prevention of fractures in primary care BMJ 330 7498 2005 1003